{"id":47840,"date":"2022-08-31T13:02:02","date_gmt":"2022-08-31T11:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/"},"modified":"2022-08-31T13:02:02","modified_gmt":"2022-08-31T11:02:02","slug":"pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/","title":{"rendered":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference"},"content":{"rendered":"
\n

NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences<\/a>, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will participate in investor meetings at the 2022 Wells Fargo Healthcare Conference at the Encore Boston Harbor in Everett, MA on September 7-9, 2022.\n<\/p>\n

<\/a><\/p>\n

\nAbout Pillar Biosciences
\n
<\/b>Pillar Biosciences is the leader in Decision Medicine\u2122, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to quickly and accurately generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar\u2019s NGS testing solutions, including the FDA-approved oncoReveal\u2122 Dx Lung and Colon Cancer Assay, are powered by the Company\u2019s proprietary SLIMamp\u00ae and PiVAT\u00ae technologies, which helps decentralize testing availability, reduces diagnostic costs and improves access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The Company has more than 20 NGS testing products available in both IVD or RUO formats, and several others in various stages of development, including a pan-cancer oncoReveal\u2122 CDx assay, and two liquid biopsy offerings, one of which is focused on the detection of minimal residual disease (MRD). Pillar\u2019s patented technologies have been shown to provide accurate and actionable clinical results in as little as 48 hours, which enables physicians to more quickly select appropriate targeted therapies and monitor the patient\u2019s response. Pillar Biosciences has operations in Natick, MA and Shanghai, China. For more information, visit www.pillar-biosciences.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor:<\/span><\/b>
Dawn Schottlandt
\n
Argot Partners
\n
212-600-1902
\n
Pillar@argotpartners.com<\/a>\n<\/p>\n

\nMedia:<\/span><\/b>
Joshua R. Mansbach
\n
Argot Partners
\n
212-600-1902
\n
Pillar@argotpartners.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will participate in investor meetings at the 2022 Wells … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47840","6":"format-standard","7":"category-industry"},"yoast_head":"\nPillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will participate in investor meetings at the 2022 Wells ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T11:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference\",\"datePublished\":\"2022-08-31T11:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/\"},\"wordCount\":300,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005171\\\/en\\\/1557482\\\/21\\\/Pillar_biosciences_logo_final_blue-transparent.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/\",\"name\":\"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005171\\\/en\\\/1557482\\\/21\\\/Pillar_biosciences_logo_final_blue-transparent.jpg\",\"datePublished\":\"2022-08-31T11:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005171\\\/en\\\/1557482\\\/21\\\/Pillar_biosciences_logo_final_blue-transparent.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005171\\\/en\\\/1557482\\\/21\\\/Pillar_biosciences_logo_final_blue-transparent.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend","og_description":"NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine\u2122, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, and Vincent Ricci, Chief Financial Officer, will participate in investor meetings at the 2022 Wells ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-31T11:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference","datePublished":"2022-08-31T11:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/"},"wordCount":300,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/","name":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg","datePublished":"2022-08-31T11:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220831005171\/en\/1557482\/21\/Pillar_biosciences_logo_final_blue-transparent.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pillar-biosciences-to-participate-in-the-2022-wells-fargo-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pillar Biosciences to Participate in the 2022 Wells Fargo Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47840"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47840\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}